Model
Edge
Lineage Cell Therapeutics
0001878732
Filing Type
4
Filing Date
3/5/2026
Updated
3/6/26, 5:48 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership